Form 4: Roivant Sciences Director Ilan Oren Reports Changes in Beneficial Ownership

Director Ilan Oren reports acquisition and disposal of Roivant Sciences Ltd. common shares related to director compensation and tax obligations.

Summary

• On April 24, 2024, Ilan Oren, a director of Roivant Sciences Ltd., reported changes in beneficial ownership of the company's common shares.
• Oren acquired 2,121 common shares as part of the Issuer's Non-Employee Director Compensation Plan, which were fully vested on the grant date.
• Additionally, 54 common shares were disposed of to cover tax withholding obligations related to the vesting and settlement of previously granted shares.
• Following these transactions, Oren beneficially owns 80,409 common shares.

Sentiment

Score: 6

Explanation: The filing reflects routine transactions related to director compensation and tax obligations, indicating a neutral sentiment.

Positives

• The acquisition of shares reflects ongoing director compensation.
• The director maintains a significant holding in the company, with 80,409 common shares.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Related Party Transactions

• The acquisition of common shares under the Non-Employee Director Compensation Plan constitutes a related party transaction.

Stakeholder Impact

• The transactions provide transparency to shareholders regarding director compensation and ownership.

Key Dates